GlassScriptPhysician profile
Won Taek Choe
NPI 1790871416
$1,668.94
in general payments reported to CMS, 2019-2025
20 companies · $493 in 2025
The $493 reported for 2025 was more than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $203 · 2021: $128 · 2022: $110 · 2023: $235 · 2024: $398 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,126.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $566.65 | 2020-2025 | Baha, Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Genzyme Corporation | $356.71 | 2020-2025 | |
| Glaxosmithkline, LLC. | $192.66 | 2019-2024 | Nucala, Trelegy Ellipta |
| Medtronic, INC. | $66.98 | 2024-2025 | Stealthstation S8 Platform, Propel |
| Novartis Pharmaceuticals Corporation | $58.28 | 2025 | |
| Inspire Medical Systems, INC. | $49.03 | 2024 | Inspire |
| Kaleo, INC. | $43.69 | 2022-2024 | Auvi-Q |
| Supernus Pharmaceuticals, INC. | $42.76 | 2019 | |
| Optinose US, INC. | $40.21 | 2023-2024 | |
| Pfizer INC. | $34.29 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $32.22 | 2023-2024 | Dupixent |
| Stryker Corporation | $31.42 | 2019 | |
| Alk-Abello, INC | $27.48 | 2019-2020 | |
| Integra Lifesciences Corporation | $24.76 | 2024 | Acclarent Aera |
| Hikma Pharmaceuticals USA | $21.11 | 2023 | Ryaltris |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Med-El Corporation | $19.32 | 2024 | Adhear Professional Kit, Bci 602 Kit |
| Paratek Pharmaceuticals, INC. | $16.95 | 2025 | Nuzyra |
| Teva Pharmaceuticals USA, INC. | $16.54 | 2020 | |
| Smith+Nephew, INC. | $15.06 | 2024 | Rapid Rhino, Coblation, Tula |
| Eyevance Pharmaceuticals LLC | $12.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Won Taek Choe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.